Bioinformatics analysis and our assays confirmed that LANCL1-AS1 was largely distributed in the cytoplasm of NSCLC cells, indicating the potential of LANCL1-AS1 as a ceRNA in NSCLC. This evidence concerns the gene LANCL1 and non-small cell lung carcinoma.